Cart
sales@molnova.com
Insulin Receptor (1142 - 1153), pTyr1150, Biotinylated
CAS No. ———
Insulin Receptor (1142 - 1153), pTyr1150, Biotinylated( ——— )
Catalog No. M41563 CAS No. ———
Insulin Receptor (1142 - 1153), pTyr1150, Biotinylated
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameInsulin Receptor (1142 - 1153), pTyr1150, Biotinylated
-
NoteResearch use only, not for human use.
-
Brief DescriptionInsulin Receptor (1142 - 1153), pTyr1150, Biotinylated
-
DescriptionInsulin Receptor (1142 - 1153), pTyr1150, Biotinylated
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight1848.08
-
Molecular FormulaC82H122N22O25S
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Shield-1
Shield-1 is a specific, high-affinity and cell-permeant ligand of FK506-binding protein-12 (FKBP), and reverses the instability by binding to mutated FKBP (mtFKBP), allowing conditional expression of mtFKBP-fused proteins. Shield-1 can stabilize the entire fusion protein.
-
Cassiaside C2
Cassiaside C2
-
MPO-IN-28
MPO-IN-28 is a novel potent irreversible Myeloperoxidase (MPO) inhibitor with IC50 of 44 nM.
